US Starts Section 301 Probe of Germany Over Pharmaceuticals
The US has begun a fresh tariff investigation into Germany over what it called “persistent underpayment for innovative pharmaceutical products,” setting the stage for levies on its goods in retaliation.
Original Source
Read the full article at Bloomberg →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.